Our vision is to establish a world premier community that will become a global destination point, to guide people along the path of prescription and alternative medicine with the help of our recommendations; based on our own research and the peer review studies. We will also provide continuous support into the research of general & alternative medicine, to improve the lives of people from around the world.
Interested in becoming our distributors?
Join usorSign In
Our factory is GMP, ISO 14001, 13485 (CE) and ISO 9001 certified to ensure the highest standard and quality of our products. Click the images below to see how we make our sap sheet or detox pads.

Printing machine in cleanroom.
Our speedy machines in action.
EasytouchTM machine (printing & sealing).
Robotic wheel with high accuracy.
Weighing machine with double digit accuracy.
Our temperature-controlled warehouse.
Our sealer machine and Q/A teams.
Our mixing machine in action.
   Our wide range of programs and services includes Q&A Support and manufacturing of patented clinically tested organic sap sheets with carbon titanium technology, hot springs shower head and other medical products - all made in our factory in Japan.

   Our recent medical advances, discoveries and inventions arising from our medical research.

Sap Sheet or Detox Patches (Patent 8317762, 12267731)
Sporopollenin (Patent 7182965, 4485940, 03720506.09)
Anti-apoptotic Lexirin (Patent 6793945, 6413556)
Processed Zeolite (Patent 36508)
More inventions
A Successful Phase 4 Clinical Trial of TRMX-3 ®
March 31st, 2013. DEFENSOR II confirms TRMX-3 ® as the ultimate key to curing many diseases.

New Distributorship Opportunity
November 30th, 2012. The availability of strategic partnership through patents, trademarks or brand names licensing.

Kenrico Granted Patent Approval For Detox Pads
November 23rd, 2012. Kenrico Sap Sheet or Detox pads has been officially patented.

DEFENSOR II study of TRMX-3 ® In Progress
March 1st, 2012. The continuation of DEFENSOR Study has been scheduled from May 2011 with its largest scale of participants.

Data from DEFENSOR study of TRMX-3 ®
January 11th, 2012. Offical report of latest clinical trials, DEFENSOR, is now available to all Kenrico's authorized distributors.


More News

Copyright © 1985-2013 Kenrico LTD. All rights reserved. Terms of Use